Where do Tyra Biosciences, Inc.'s ratios come from?

Every ratio is computed from Tyra Biosciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Returns
Return on equity	-36.9%-9.8pp	-39.8%-8.2pp	-34.7%-6.1pp	-31.2%-4.9pp	-27%-3.4pp
Return on assets	-34.7%-8.9pp	-37.1%-7.8pp	-32.7%-5.7pp	-29.6%-4.5pp	-25.8%-2.9pp
Return on invested capital	-53.2%+8.1pp	-59.7%-8.9pp	-51.5%+20.7pp	-49.4%+15.3pp	-61.3%+54.6pp
Liquidity
Current ratio	20.5×-2.3×	14.7×-9.1×	17.7×-11.8×	21.9×-14.5×	22.8×-22.1×
Quick ratio	20.5×-2.3×	14.7×-9.1×	17.7×-11.8×	21.9×-14.5×	22.8×-22.1×
Cash ratio	4.4×-2.7×	4.3×-2.0×	3.9×-4.5×	7.2×-2.4×	7.1×-22.1×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Per Share
Book value per share	$6.28+15.1%	$4.35-27.5%	$4.70-23.6%	$5.07-20.8%	$5.45-27.0%
Valuation
Market capitalization	$2.06B+318%	$1.4B+99.5%	$745.63M-46.1%	$517.95M-44.8%	$493.74M-42.4%
Enterprise value	$1.98B+397%	$1.33B+116%	$689.59M-46.4%	$425.49M-49.6%	$399.14M-34.4%
Price / book	5.3×+3.8×	5.4×+3.4×	2.7×-1.2×	1.7×-0.8×	1.5×-0.7×
Free cash flow yield	-5%+10.0pp	-6.8%+3.2pp	-12.2%-7.5pp	-16.7%-9.9pp	-14.9%-7.6pp
Earnings yield	-6.4%+13.2pp	-8.5%+3.7pp	-15%-8.9pp	-20.4%-11.8pp	-19.5%-10.7pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Tyra Biosciences, Inc.'s ratios come from?: Every ratio is computed from Tyra Biosciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.